Harbour Capital Advisors’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $444K | Hold |
1,221
| – | – | 0.08% | 206 |
|
|
2026
Q1 | $422K | Buy |
1,221
+250
| +26% | +$89.1K | 0.08% | 205 |
|
|
2025
Q4 | $318K | Hold |
971
| – | – | 0.06% | 221 |
|
|
2025
Q3 | $287K | Sell |
971
-116
| -11% | -$33.6K | 0.06% | 244 |
|
|
2025
Q2 | $323K | Sell |
1,087
-9
| -0.8% | -$2.55K | 0.07% | 231 |
|
|
2025
Q1 | $340K | Sell |
1,096
-50
| -4% | -$14.8K | 0.08% | 210 |
|
|
2024
Q4 | $299K | Hold |
1,146
| – | – | 0.07% | 235 |
|
|
2024
Q3 | $369K | Hold |
1,146
| – | – | 0.09% | 208 |
|
|
2024
Q2 | $356K | Hold |
1,146
| – | – | 0.08% | 214 |
|
|
2024
Q1 | $317K | Buy |
1,146
+57
| +5% | +$16.7K | 0.08% | 224 |
|
|
2023
Q4 | $327K | Sell |
1,089
-25
| -2% | -$6.81K | 0.09% | 203 |
|
|
2023
Q3 | $299K | Sell |
1,114
-11
| -1% | -$2.75K | 0.09% | 199 |
|
|
2023
Q2 | $253K | Sell |
1,125
-19
| -2% | -$4.41K | 0.07% | 222 |
|
|
2023
Q1 | $277K | Sell |
1,144
-30
| -3% | -$7.36K | 0.08% | 207 |
|
|
2022
Q4 | $307K | Sell |
1,174
-50
| -4% | -$13.4K | 0.1% | 174 |
|
|
2022
Q3 | $284K | Hold |
1,224
| – | – | 0.1% | 177 |
|
|
2022
Q2 | $298K | Sell |
1,224
-30
| -2% | -$7.35K | 0.1% | 177 |
|
|
2022
Q1 | $303K | Hold |
1,254
| – | – | 0.08% | 182 |
|
|
2021
Q4 | $282K | Sell |
1,254
-50
| -4% | -$10.6K | 0.07% | 201 |
|
|
2021
Q3 | $277K | Buy |
1,304
+100
| +8% | +$23K | 0.07% | 207 |
|
|
2021
Q2 | $293K | Hold |
1,204
| – | – | 0.08% | 195 |
|
|
2021
Q1 | $300K | Buy |
+1,204
| New | +$287K | 0.09% | 182 |
|
|
2020
Q4 | – | Sell |
-1,424
| Closed | -$362K | – | 75 |
|
|
2020
Q3 | $362K | Hold |
1,424
| – | – | 0.13% | 150 |
|
|
2020
Q2 | $336K | Hold |
1,424
| – | – | 0.14% | 145 |
|
|
2020
Q1 | $289K | Sell |
1,424
-20
| -1% | -$4.37K | 0.15% | 136 |
|
|
2019
Q4 | $348K | Hold |
1,444
| – | – | 0.13% | 159 |
|
|
2019
Q3 | $279K | Sell |
1,444
-50
| -3% | -$9.6K | 0.12% | 168 |
|
|
2019
Q2 | $275K | Hold |
1,494
| – | – | 0.12% | 170 |
|
|
2019
Q1 | $284K | Sell |
1,494
-35
| -2% | -$6.68K | 0.13% | 168 |
|
|
2018
Q4 | $298K | Sell |
1,529
-90
| -6% | -$17.6K | 0.15% | 157 |
|
|
2018
Q3 | $336K | Sell |
1,619
-15
| -0.9% | -$2.96K | 0.14% | 135 |
|
|
2018
Q2 | $303K | Sell |
1,634
-40
| -2% | -$7.08K | 0.13% | 174 |
|
|
2018
Q1 | $285K | Sell |
1,674
-105
| -6% | -$19.3K | 0.12% | 191 |
|
|
2017
Q4 | $309K | Sell |
1,779
-5
| -0.3% | -$885 | 0.13% | 180 |
|
|
2017
Q3 | $333K | Sell |
1,784
-75
| -4% | -$13.3K | 0.15% | 175 |
|
|
2017
Q2 | $320K | Sell |
1,859
-320
| -15% | -$52K | 0.16% | 164 |
|
|
2017
Q1 | $358K | Sell |
2,179
-125
| -5% | -$20.8K | 0.16% | 158 |
|
|
2016
Q4 | $337K | Buy |
2,304
+1,000
| +77% | +$151K | 0.24% | 125 |
|
|
2016
Q3 | $218K | Sell |
1,304
-30
| -2% | -$5.07K | 0.14% | 178 |
|
|
2016
Q2 | $203K | Hold |
1,334
| – | – | 0.11% | 212 |
|
|
2016
Q1 | $200K | Hold |
1,334
| – | – | 0.11% | 204 |
|
|
2015
Q4 | $217K | Buy |
+1,334
| New | +$210K | 0.12% | 204 |
|
|
2015
Q3 | – | Sell |
-1,334
| Closed | -$205K | – | 193 |
|
|
2015
Q2 | $205K | Buy |
1,334
+60
| +5% | +$9.61K | 0.13% | 193 |
|
|
2015
Q1 | $204K | Buy |
+1,274
| New | +$201K | 0.14% | 179 |
|
Other funds holding AMGN
FFM
SP
Harbour Capital Advisors's AMGN Position: Q2 2026 in Review
Harbour Capital Advisors held its Amgen (AMGN) position steady in Q2 2026 at 1,221 shares worth $444K. The position accounts for 0.08% of the portfolio, ranked #206.
Harbour Capital Advisors first reported a position in AMGN in Q1 2015 and has held it in 44 quarters since. 1,278 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Harbour Capital Advisors held 1,221 shares of Amgen worth $444K as of Q2 2026.
- Harbour Capital Advisors left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.08% of Harbour Capital Advisors's portfolio in Q2 2026, its #206 holding.
- Harbour Capital Advisors first reported a position in Amgen in Q1 2015 and has held it in 44 quarters since.
- 1,278 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Harbour Capital Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.